Corbus Pharmaceuticals Holdi

Biotech Stocks Healthcare Stocks

$10.25

+0.86 (+9.16%)

As of Apr 1, 2:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +18.5% upside

Low Target $8.71

Average Target $12.15

High Target $17.60

Current Price $10.25

Current
$10.25

Target
$12.15

$8.71 $12.15 avg $17.60

Scenario Analysis

Bear Case

$8.71

-15.0%

Low target

Base Case

$12.15

+18.5%

Avg target

Bull Case

$17.60

+71.7%

High target

Risk/Reward

4.8x

Highly favorable

Price in Context

52-Week High

$20.56

-50.1% from high

52-Week Low

$4.64

+120.9% from low

Target vs 52W High

$12.15

-40.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%